Genomic structure and promoter analysis of PKC-delta.
Protein kinase C-delta (PKC-delta) is a ubiquitously expressed kinase involved in a variety of cellular signaling pathways including cell growth, differentiation, apoptosis, tumor promotion, and carcinogenesis. While signaling pathways downstream of PKC-delta are well studied, the regulation of the gene has not been extensively analyzed. A mouse genomic DNA fragment containing the PKC-delta gene was sequenced by the primer-walking method, and the subsequent DNA sequence data were used as a query to clone Caenorhabditis elegans and human genomic homologs from the publicly available genomic databases. The genomic structures of C. elegans, mouse, rat, and human PKC-delta were analyzed, and the result revealed that PKC-delta genes comprise 12, 18, 19, and 18 exons for C. elegans, mouse, rat, and human, respectively. The translation start methionine resides in the second exon in mouse and human and in the third exon in rat. The first intron between the first exon and the exon with the translation start methionine in mammalian genes represents a very large gap, as long as 17 kb in human, indicating a complexity involved in gene splicing. Overall exon-intron genomic structure is highly conserved among mammals, while significantly diverged in C. elegans. Putative transcription factor binding sites on the 1.7-kb promoter region of the mouse gene suggest that PKC-delta might be involved in spermatogenesis, embryogenesis, development, brain generation, immune response, oxidative environment, and oncogenesis. Studies on the promoter and subsequent biological testing on mouse keratinocytes indicate that tumor necrosis factor (TNF)-alpha increases the expression of PKC-delta, and this correlates with the time of NFkappaB nuclear translocation and activation. This TNF-alpha-mediated upregulation of PKC-delta is repressed in keratinocytes that are preinfected with IkappaB superrepressor adenovirus, suggesting that NFkappaB is involved directly in PKC-delta expression.
Suh
Kwang S
KS
Laboratory of Cellular Carcinogenesis and Tumor Promotion, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Tatunchak
Tamara T
TT
Crutchley
John M
JM
Edwards
Lindsay E
LE
Marin
Keith G
KG
Yuspa
Stuart H
SH
D000818:Animals; D000831:Animals, Newborn; D001483:Base Sequence; D017173:Caenorhabditis elegans / Q000235:genetics; D002478:Cells, Cultured; D019143:Evolution, Molecular; D005091:Exons; D005796:Genes / Q000235:genetics*; D016678:Genome; D015894:Genome, Human; D006801:Humans; D007438:Introns; D007527:Isoenzymes / Q000235:genetics* / Q000378:metabolism; D015603:Keratinocytes / Q000201:enzymology; D051379:Mice; D008807:Mice, Inbred BALB C; D011401:Promoter Regions, Genetic; D011493:Protein Kinase C / Q000235:genetics* / Q000378:metabolism; D051381:Rats; D012045:Regulatory Sequences, Nucleic Acid; D017422:Sequence Analysis, DNA; D013045:Species Specificity; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology / Q000502:physiology
D007527:Isoenzymes; D014409:Tumor Necrosis Factor-alpha; D011493:Protein Kinase C